Session 168-Poster Abstracts
HIV Drug Resistance and Tropism (after Treatment Failure) in Children
Thursday, 2-4 pm; Poster Hall
      988 Extensive Drug Resistance in HIV+ Children Failing First-line ART Is Undetected by WHO 2010 Guidelines: Cambodia
B Westley1, A DeLong1, T Chhraing2, S Dim2, E Nerrienet3, L Schreier1, J Hogan1, and Rami Kantor*1
1Brown Univ, Providence, RI, US; 2Angkor Hosp for Children, Siem Reap, Cambodia; and 3Inst Pasteur, Phnom Penh, Cambodia
      989

Nevirapine Resistance in Nevirapine-unexposed HIV-1+ Infants Initiating Nevirapine-based ART: Nairobi, Kenya
Bhavna Chohan*1,2, S Benki-Nugent2, K Tapia2, M Nga’yo3, B Khasimwa1, D Lehman4, D Wamalwa1, J Overbaugh4, and G John-Stewart2
1Univ of Nairobi, Kenya; 2Univ of Washington, Seattle, US; 3Kenya Med Res Inst, Nairobi; and 4Fred Hutchinson Cancer Res Ctr, Seattle, WA, US
      990 Absence of Integrase Inhibitor Resistance Mutations in Children Not Treated with Integrase Inhibitors
Julie Nelson*1, A Loftis1, K Below1, D Cole1, S Nachman2, L Frenkel3, C Alvero4, N Zheng4, J Eron1, and S Fiscus1
1Univ of North Carolina at Chapel Hill, US; 2State Univ of New York at Stony Brook, US; 3Univ of Washington, Seattle, US; and 4Harvard Sch of Publ Hlth, Boston, MA, US
      991

Could CCR5-antagonists Be a Therapeutic Option in HIV-1 Perinatally Infected Children Experiencing Virologic Failure?: Necker Hospital, Paris, France
Pierre Frange*, S Blanche, F Veber, D Moshous, V Avettand-Fenoël, C Rouzioux, and M-L Chaix
Hosp Necker, Paris, France